DVAX250516C10000
- 0.73
- 0.000.00%
Dynavax Technologies Newsroom
Dynavax Technologies Analyst Ratings
Goldman Sachs Maintains Dynavax Technologies(DVAX.US) With Sell Rating, Cuts Target Price to $10
William Blair Maintains Dynavax Technologies(DVAX.US) With Buy Rating
A Quick Look at Today's Ratings for Dynavax Technologies(DVAX.US), With a Forecast Between $25 to $33
Dynavax Technologies Analyst Ratings
Goldman Sachs Downgrades Dynavax Technologies(DVAX.US) to Sell Rating, Cuts Target Price to $12
H.C. Wainwright Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Raises Target Price to $31
Dynavax Is Maintained at Buy by HC Wainwright & Co.
Dynavax Technologies Analyst Ratings
TD Cowen Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $25
JMP Securities Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $29
TD Cowen Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $25
H.C. Wainwright Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $29
Dynavax Technologies Analyst Ratings
JMP Securities Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $29
Dynavax Technologies: Strong Buy Rating Backed by HEPLISAV-B Growth and Strategic Initiatives
TD Cowen Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $25
JMP Securities Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $29
Dynavax Technologies Analyst Ratings
H.C. Wainwright Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $29